| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,570 | 0,620 | 14:39 | |
| 0,585 | 0,615 | 14:41 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23.09. | ACOTEC-B (06669): NOTIFICATION LETTER AND REPLY FORM TO NON-REGISTERED SHAREHOLDERS | - | HKEx | ||
| 23.09. | ACOTEC-B (06669): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS | - | HKEx | ||
| 31.08. | ACOTEC-B (06669): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026 | 1 | HKEx | ||
| 19.08. | ACOTEC-B (06669): NOTICE OF BOARD MEETING | - | HKEx | ||
| 12.08. | ACOTEC-B (06669): INSIDE INFORMATION PROFIT WARNING | - | HKEx | ||
| 16.06. | ACOTEC-B (06669): AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION | 2 | HKEx | ||
| 16.06. | ACOTEC-B (06669): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON TUESDAY, JUNE 16, 2026 | - | HKEx | ||
| 22.05. | ACOTEC-B (06669): NOTIFICATION LETTER AND REPLY FORM TO NON-REGISTERED SHAREHOLDERS | - | HKEx | ||
| ACOTEC SCIENTIFIC Aktie jetzt für 0€ handeln | |||||
| 22.05. | ACOTEC-B (06669): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS | - | HKEx | ||
| 22.05. | ACOTEC-B (06669): FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON TUESDAY, JUNE 16, 2026 | - | HKEx | ||
| 22.05. | ACOTEC-B (06669): NOTICE OF ANNUAL GENERAL MEETING | 1 | HKEx | ||
| 22.05. | ACOTEC-B (06669): PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES; RE-ELECTION OF RETIRING DIRECTORS; RE-APPOINTMENT OF AUDITOR; ... | 1 | HKEx |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| RESMED | 224,00 | -3,45 % | Resmed Inc Q1 Income Advances | WASHINGTON (dpa-AFX) - Resmed Inc (RMD.AX) released a profit for its first quarter that Increases, from last yearThe company's bottom line totaled $418.413 million, or $2.92 per share. This... ► Artikel lesen | |
| CARDINAL HEALTH | 230,00 | +2,22 % | Dividendenbekanntmachungen (15.10.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABBOTT LABORATORIES US0028241000 0,63 USD 0,5648 EUR ABBOTT LABORATORIES CDR CA0028221046 0,1096 CAD 0,069 EUR ABBVIE INC US00287Y1091 1... ► Artikel lesen | |
| ZIMMER BIOMET | 84,20 | 0,00 % | Dividendenbekanntmachungen (30.10.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACRES COMMERCIAL REALTY CORP PFD D US00489Q3002 0,4921 USD EUR ACROW LIMITED AU0000006124 0,0142 AUD EUR ADENTRA INC CA00686A1084 0... ► Artikel lesen | |
| UNIDOC HEALTH | 0,038 | +6,78 % | CSE Bulletin: Reinstatement - UniDoc Health Corp. (UDOC) | Le 7 octobre/October 2026
Effective immediately, UniDoc Health Corp. will be reinstated for trading.
The Company has rectified the default situation that gave rise to the suspension.
__________________________
En... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,395 | 0,00 % | Co-Diagnostics' Joint Venture CoSara Diagnostics Completes Clinical Study and Regulatory Submission for Point-of-Care Tuberculosis Test, Sets Stage for Commercial Launch in India | CDSCO Clearance and Commercial Launch in India Anticipated Before Year-End 2026Study Demonstrated 97.3% Sensitivity and 96.0% SpecificityConsistent Performance Across Three Test BatchesIntegrated Mobile... ► Artikel lesen | |
| CLARIANE | 3,172 | 0,00 % | Clariane 9M 2026 slides: occupancy hits 93%, €2.3bn refinancing done | ||
| INSPIREMD | 0,416 | +2,97 % | InspireMD Inc.: InspireMD Announces Amendments to Certain Series J and Series K Warrants, Providing Potential Gross Proceeds of Up to $11 Million | - Amendments align trigger event of existing warrants with anticipated FDA approval of CGuard Prime 80 cm, which the Company continues to anticipate in Q4 2026 - - The amended warrants, if exercised... ► Artikel lesen | |
| VYOME | 1,750 | 0,00 % | Vyome Welcomes Jerry Leonard as New Chief Financial Officer | ||
| IZOTROPIC | 0,094 | +2,19 % | Izotropic Corporation: Izotropic Closes Non-Brokered Private Placement | Vancouver, British Columbia and Casablanca, Morocco--(Newsfile Corp. - October 6, 2026) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device... ► Artikel lesen | |
| ASTRANA HEALTH | 33,000 | +0,61 % | Astrana Health, Inc. Reports Second Quarter 2026 Results | Company to Host Conference Call on Thursday, August 6, 2026, at 2:30 p.m. PT/5:30 p.m. ET
Reports revenue of $972.5 million, up 49% year-over-year, net income... ► Artikel lesen | |
| ORGANOGENESIS | 0,735 | 0,00 % | Johnson & Johnson, GSK und Co.: Warum der Wettlauf um Zelltherapie-Plattformen gerade erst beginnt | ||
| ORIOLA | 0,775 | 0,00 % | Oriola Corporation: Oriola Corporation's Interim Report 1 January-30 September 2026 | Oriola Corporation Stock Exchange Release 29 October 2026 at 8.30 a.m. EET
Oriola Corporation's Interim Report 1 January-30 September 2026
Progress on strategic priorities and core business performance
July-September... ► Artikel lesen | |
| CROSSJECT | 1,270 | 0,00 % | CROSSJECT Reports Its First-Half 2026 Results and Presents a Significantly Strengthened Financial Structure | Cash and cash equivalents of €12.3 million as of June 30, 2026, a 2.4-fold increase compared to December 31, 2025 (€5.1 million), following the €15 million capital increase completed in May. Shareholders'... ► Artikel lesen | |
| BAUSCH+LOMB | 18,300 | 0,00 % | Stocks in Play: Bausch + Lomb Corporation | ||
| CARVOLIX | 5,800 | +0,69 % | Carvolix Appoints Anne Lange as Chair of its Board of Directors Confirming the Acceleration of its Ambitions and Reports 2026 Half-Year Results. | DJ Carvolix Appoints Anne Lange as Chair of its Board of Directors Confirming the Acceleration of its Ambitions and Reports 2026 Half-Year Results.
Affluent Medical
Carvolix Appoints Anne Lange... ► Artikel lesen |